Replicel Life Sciences Inc (RP.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 88 | 88 | 88 | 88 | 88 |
| Operating Expenses | 414 | 286 | 551 | 472 | 273 |
| Operating Income | -325 | -197 | -463 | -384 | -184 |
| Interest Expense | 0 | 0 | 0 | 2 | 3 |
| Other Income | -493 | -361 | -501 | 2,656 | -928 |
| Pre-tax Income | -819 | -559 | -963 | 2,271 | -1,116 |
| Net Income Continuous | -819 | -558 | -963 | 2,271 | -1,116 |
| Net Income | $-819 | $-558 | $-963 | $2,271 | $-1,116 |
| EPS Basic Total Ops | -0.01 | -0.01 | -0.01 | 0.03 | -0.03 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | -0.01 | 0.03 | -0.03 |
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.01 | 0.03 | -0.03 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | -0.01 | 0.03 | -0.03 |
| EBITDA(a) | $-819 | $-557 | $-963 | $2,273 | $-1,112 |